High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease

BACKGROUND: The patho‐mechanism of ocular surface disease (OSD) in dupilumab‐treated atopic dermatitis (AD) patients remains unclear. The aim of this study is to measure dupilumab levels in tear fluid and serum, and relate these findings to the severity of OSD during dupilumab treatment in AD patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Achten, Roselie, Thijs, Judith, van der Wal, Marlot, van Luijk, Chantal, van Luin, Matthijs, el Amrani, Mohsin, Knol, Edward, Delemarre, Eveline, Jager, Constance den Hartog, de Graaf, Marlies, Bakker, Daphne, de Boer, Joke, van Wijk, Femke, de Bruin‐Weller, Marjolein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842774/
https://www.ncbi.nlm.nih.gov/pubmed/36705509
http://dx.doi.org/10.1002/clt2.12221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842774/
https://www.ncbi.nlm.nih.gov/pubmed/36705509
http://dx.doi.org/10.1002/clt2.12221

Ejemplares similares